Cargando…
Serum Neurofilament Light Chain Levels May Be a Marker of Lower Motor Neuron Damage in Amyotrophic Lateral Sclerosis
Objectives The aims of this study were to investigate whether serum neurofilament light chain (NfL) levels were correlated with the severity of the axonal degeneration of lower motor neurons (LMNs) in the early symptomatic phase of amyotrophic lateral sclerosis (ALS). Methods In this prospective stu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905596/ https://www.ncbi.nlm.nih.gov/pubmed/35280276 http://dx.doi.org/10.3389/fneur.2022.833507 |
_version_ | 1784665221389877248 |
---|---|
author | Zhang, Linjing Ji, Tuo Wu, Chujun Zhang, Shuo Tang, Lu Zhang, Nan Liu, Xiangyi Fan, Dongsheng |
author_facet | Zhang, Linjing Ji, Tuo Wu, Chujun Zhang, Shuo Tang, Lu Zhang, Nan Liu, Xiangyi Fan, Dongsheng |
author_sort | Zhang, Linjing |
collection | PubMed |
description | Objectives The aims of this study were to investigate whether serum neurofilament light chain (NfL) levels were correlated with the severity of the axonal degeneration of lower motor neurons (LMNs) in the early symptomatic phase of amyotrophic lateral sclerosis (ALS). Methods In this prospective study, the serum samples used for NfL measurement were obtained from 103 sporadic ALS outpatients within 2 years of disease duration. The severity of axonal degeneration was assessed by assessing the decrease in the compound muscle action potentials (CMAPs) within a 1-month interval from serum sampling. Results The NfL levels showed a significant positive correlation with the relative score as a proxy for the axonal damage of LMNs in patients with ALS (coefficient: 0.264, p = 0.009). Furthermore, this correlation became stronger (coefficient: 0.582, p = 0.037) when estimated only among patients with disease subtypes that involve only LMNs, that is, patients with flail arm or leg syndrome (FAS or FLS). The levels of NfL increased with the severity of axonal damage of LMNs (F = 6.694, P = 0.0001). Conclusions Serum NfL levels mirrored the severity of the axonal degeneration of LMNs, particularly in patients with signs of predominant LMN involvement. These results may have a profound effect on the selection of patients and the monitoring of treatment efficacy in future disease-modifying clinical trials. |
format | Online Article Text |
id | pubmed-8905596 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89055962022-03-10 Serum Neurofilament Light Chain Levels May Be a Marker of Lower Motor Neuron Damage in Amyotrophic Lateral Sclerosis Zhang, Linjing Ji, Tuo Wu, Chujun Zhang, Shuo Tang, Lu Zhang, Nan Liu, Xiangyi Fan, Dongsheng Front Neurol Neurology Objectives The aims of this study were to investigate whether serum neurofilament light chain (NfL) levels were correlated with the severity of the axonal degeneration of lower motor neurons (LMNs) in the early symptomatic phase of amyotrophic lateral sclerosis (ALS). Methods In this prospective study, the serum samples used for NfL measurement were obtained from 103 sporadic ALS outpatients within 2 years of disease duration. The severity of axonal degeneration was assessed by assessing the decrease in the compound muscle action potentials (CMAPs) within a 1-month interval from serum sampling. Results The NfL levels showed a significant positive correlation with the relative score as a proxy for the axonal damage of LMNs in patients with ALS (coefficient: 0.264, p = 0.009). Furthermore, this correlation became stronger (coefficient: 0.582, p = 0.037) when estimated only among patients with disease subtypes that involve only LMNs, that is, patients with flail arm or leg syndrome (FAS or FLS). The levels of NfL increased with the severity of axonal damage of LMNs (F = 6.694, P = 0.0001). Conclusions Serum NfL levels mirrored the severity of the axonal degeneration of LMNs, particularly in patients with signs of predominant LMN involvement. These results may have a profound effect on the selection of patients and the monitoring of treatment efficacy in future disease-modifying clinical trials. Frontiers Media S.A. 2022-02-23 /pmc/articles/PMC8905596/ /pubmed/35280276 http://dx.doi.org/10.3389/fneur.2022.833507 Text en Copyright © 2022 Zhang, Ji, Wu, Zhang, Tang, Zhang, Liu and Fan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Zhang, Linjing Ji, Tuo Wu, Chujun Zhang, Shuo Tang, Lu Zhang, Nan Liu, Xiangyi Fan, Dongsheng Serum Neurofilament Light Chain Levels May Be a Marker of Lower Motor Neuron Damage in Amyotrophic Lateral Sclerosis |
title | Serum Neurofilament Light Chain Levels May Be a Marker of Lower Motor Neuron Damage in Amyotrophic Lateral Sclerosis |
title_full | Serum Neurofilament Light Chain Levels May Be a Marker of Lower Motor Neuron Damage in Amyotrophic Lateral Sclerosis |
title_fullStr | Serum Neurofilament Light Chain Levels May Be a Marker of Lower Motor Neuron Damage in Amyotrophic Lateral Sclerosis |
title_full_unstemmed | Serum Neurofilament Light Chain Levels May Be a Marker of Lower Motor Neuron Damage in Amyotrophic Lateral Sclerosis |
title_short | Serum Neurofilament Light Chain Levels May Be a Marker of Lower Motor Neuron Damage in Amyotrophic Lateral Sclerosis |
title_sort | serum neurofilament light chain levels may be a marker of lower motor neuron damage in amyotrophic lateral sclerosis |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905596/ https://www.ncbi.nlm.nih.gov/pubmed/35280276 http://dx.doi.org/10.3389/fneur.2022.833507 |
work_keys_str_mv | AT zhanglinjing serumneurofilamentlightchainlevelsmaybeamarkeroflowermotorneurondamageinamyotrophiclateralsclerosis AT jituo serumneurofilamentlightchainlevelsmaybeamarkeroflowermotorneurondamageinamyotrophiclateralsclerosis AT wuchujun serumneurofilamentlightchainlevelsmaybeamarkeroflowermotorneurondamageinamyotrophiclateralsclerosis AT zhangshuo serumneurofilamentlightchainlevelsmaybeamarkeroflowermotorneurondamageinamyotrophiclateralsclerosis AT tanglu serumneurofilamentlightchainlevelsmaybeamarkeroflowermotorneurondamageinamyotrophiclateralsclerosis AT zhangnan serumneurofilamentlightchainlevelsmaybeamarkeroflowermotorneurondamageinamyotrophiclateralsclerosis AT liuxiangyi serumneurofilamentlightchainlevelsmaybeamarkeroflowermotorneurondamageinamyotrophiclateralsclerosis AT fandongsheng serumneurofilamentlightchainlevelsmaybeamarkeroflowermotorneurondamageinamyotrophiclateralsclerosis |